ACONW
Aclarion, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.03
+17.65%Price chart
Sep 22Sep 28Oct 1Oct 6Oct 14Oct 21Oct 29Nov 3
Key dataNov 3, 2026
Open$0.05
From 52W high−74.78%
Volume4089.00
Market cap$15141.65
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataNov 3, 2026
Open
$0.05
From 52W high
−74.78%
Volume
4089.00
Market cap
$15141.65
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
1.8x
P/E (TTM)
—
RSI (14)
46.2
MomentumView details →
1D Return
+17.65%
YTD Return
−41.69%
SummaryUpdated Jun 1, 2026
Aclarion, Inc. (NASDAQ:ACON) is a healthcare technology company founded in 2008 and headquartered in San Mateo, California. Originally known as Nocimed, Inc., the company changed its name to Aclarion in December 2021 and went public in April 2022. The company specializes in developing software applications for magnetic resonance spectroscopy (MRS) technology, specifically targeting the diagnosis and treatment of degenerative spinal conditions. As a relatively young public company, Aclarion operates in the emerging field of medical imaging software, focusing on providing clinicians with advanced diagnostic tools to better understand and treat chronic back pain.
Similar companies
Latest newsMore news →
Aclarion announced a new real-world publication reporting strong agreement between its Nociscan platform and discography in diagnosing painful lumbar discs.13d agoAclarion announced that revised enrollment criteria for its CLARITY clinical trial had been approved at nine of the trial’s eleven active sites.27d agoAclarion, Inc. announced that NYU Langone Health joined its CLARITY randomized clinical trial as a new clinical site, bringing enrollment to eleven sites.36d ago